GEVI vs SNES
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEVI is a Hold and SNES is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GEVI’s FA Score shows that 1 FA rating(s) are green whileSNES’s FA Score has 0 green FA rating(s).
- GEVI’s FA Score: 1 green, 4 red.
- SNES’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SNES’s TA Score shows that 5 TA indicator(s) are bullish.
- SNES’s TA Score: 5 bullish, 3 bearish.
Price Growth
GEVI (@Chemicals: Specialty) experienced а -8.73% price change this week, while SNES (@Chemicals: Specialty) price change was +10.26% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -1.46%. For the same industry, the average monthly price growth was -2.13%, and the average quarterly price growth was -5.42%.
Reported Earning Dates
GEVI is expected to report earnings on Mar 31, 2023.
SNES is expected to report earnings on May 11, 2023.
Industries' Descriptions
@Chemicals: Specialty (-1.46% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
| GEVI | SNES | GEVI / SNES | |
| Capitalization | 41.9M | 3.54M | 1,185% |
| EBITDA | -3.24M | -7.57M | 43% |
| Gain YTD | 0.027 | 0.604 | 5% |
| P/E Ratio | N/A | 0.00 | - |
| Revenue | 118K | 1.19M | 10% |
| Total Cash | 63.5K | 5.4M | 1% |
| Total Debt | 59.8K | 406K | 15% |
GEVI | SNES | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 54 | 81 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 88 Overvalued | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 32 | 100 | |
SMR RATING 1..100 | 99 | 99 | |
PRICE GROWTH RATING 1..100 | 63 | 49 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SNES's Valuation (66) in the Biotechnology industry is in the same range as GEVI (88) in the null industry. This means that SNES’s stock grew similarly to GEVI’s over the last 12 months.
GEVI's Profit vs Risk Rating (32) in the null industry is significantly better than the same rating for SNES (100) in the Biotechnology industry. This means that GEVI’s stock grew significantly faster than SNES’s over the last 12 months.
GEVI's SMR Rating (99) in the null industry is in the same range as SNES (99) in the Biotechnology industry. This means that GEVI’s stock grew similarly to SNES’s over the last 12 months.
SNES's Price Growth Rating (49) in the Biotechnology industry is in the same range as GEVI (63) in the null industry. This means that SNES’s stock grew similarly to GEVI’s over the last 12 months.
SNES's P/E Growth Rating (100) in the Biotechnology industry is in the same range as GEVI (100) in the null industry. This means that SNES’s stock grew similarly to GEVI’s over the last 12 months.
| SNES | |
|---|---|
| RSI ODDS (%) | N/A |
| Stochastic ODDS (%) | 6 days ago 79% |
| Momentum ODDS (%) | 6 days ago 82% |
| MACD ODDS (%) | 6 days ago 82% |
| TrendWeek ODDS (%) | 6 days ago 80% |
| TrendMonth ODDS (%) | 6 days ago 81% |
| Advances ODDS (%) | 10 days ago 77% |
| Declines ODDS (%) | 13 days ago 90% |
| BollingerBands ODDS (%) | 6 days ago 90% |
| Aroon ODDS (%) | 6 days ago 90% |
GEVI and
Correlation & Price change
A.I.dvisor tells us that GEVI and SNES have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GEVI and SNES's prices will move in lockstep.
| Ticker / NAME | Correlation To GEVI | 1D Price Change % | ||
|---|---|---|---|---|
| GEVI | 100% | -18.88% | ||
| SNES - GEVI | 25% Poorly correlated | -2.35% | ||
| YIPCF - GEVI | 20% Poorly correlated | N/A | ||
| ORGN - GEVI | 12% Poorly correlated | +0.80% | ||
| VBVBF - GEVI | 7% Poorly correlated | N/A | ||
| LNXSY - GEVI | 3% Poorly correlated | -0.15% | ||
More | ||||
SNES and
Correlation & Price change
A.I.dvisor tells us that SNES and GEVI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNES and GEVI's prices will move in lockstep.
| Ticker / NAME | Correlation To SNES | 1D Price Change % | ||
|---|---|---|---|---|
| SNES | 100% | -2.35% | ||
| GEVI - SNES | 25% Poorly correlated | -18.88% | ||
| BIOF - SNES | 21% Poorly correlated | -3.28% | ||
| KANKF - SNES | 20% Poorly correlated | N/A | ||
| LOOP - SNES | 7% Poorly correlated | +17.92% | ||
| AXTA - SNES | 4% Poorly correlated | +0.16% | ||
More | ||||